Oncologic Drug Repository Programs in the United States: A Review and Comparison

Abstract

As cancer affects forty percent of all Americans during their lifetime, the financial burden of cancer care represents a significant contribution towards the overall cost of healthcare in the United States. Cancer drug repository programs offer a unique solution for patients who have limited financial ability to access medications while reducing medical waste. We reviewed all state legislation in the United States regarding cancer drug repository programs. Five states have OACD-specific drug repository programs, while 28 states have generalized drug repository programs. Iowa’s state-wide, mail-order OACD repository program is the preeminent example of an effective and efficient program which should be replicated across the country. Many states have passed legislation allowing for drug repository programs but have struggled to translate such legislation into active programs due to lack of funding and management. We offer recommendations across policy, manufacturing, institutional, healthcare professional and patient domains in order provide optimal patient care.